Studies on controlled release dimenhydrinate from matrix tablet formulations

Pharmaceutica Acta Helvetiae

Volumn 74, Issue 1, 1999, Pages 43-49

  Genç, Lütfi ^a   Bilaç, Hadi ^a   Güler, Erden ^a  

^a ANADOLU UNIVERSITY   (Turkey)

Author keywords

Carbopol; Controlled release; Dimenhydrinate; Eudragit; HEC; Matrix tablet; MC

Indexed keywords

CARBOPOL 934; DIMENHYDRINATE; EUDRAGIT; HYDROXYETHYLCELLULOSE; LUBRICATING AGENT; MAGNESIUM STEARATE; METHYLCELLULOSE; POLYMER; STARCH;

ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DISSOLUTION; DRUG DOSAGE FORM; DRUG FORMULATION; GEL; HEIGHT; PH; QUALITY CONTROL; TABLET; TABLET COMPRESSION; TECHNIQUE; WEIGHT;

CHEMISTRY, PHARMACEUTICAL; DIMENHYDRINATE; DRUG DELIVERY SYSTEMS; HISTAMINE H1 ANTAGONISTS; SOLUBILITY; TABLETS;

EID: 0033385682     PISSN: 00316865     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-6865(99)00017-5     Document Type: Article

References (29)

1. Agabeyoglu, T.I., 1984. Dissol; A basic computer program for the kinetic assessment of dissolution data, Presented at National Pharmaceutical Congress, Istanbul.
2. Al-Hmoud H., Efentakis M., Choulis N.H. A controlled release matrix using a mixture of hydrophilic and hydrophobic polymers. Int. J. Pharm. 68(1-3):1991;R1-R3.
3. Aoki S., Ando H., Machida R., Ida K., Watanabe S., Ozawa H. Sustained release matrix using hydroxypropylcellulose-ethylcellulose complex as a filler. Chem. Pharm. Bull. 41(8):1993;1438-1443.
4. Bettini R., Colombo P., Massimo G., Catellani P.l., Vitali T. Swelling and drug release in hydrogel matrices: polymer viscosity and matrix porosity effects. Eur. J. Pharm. Sci. 2(3):1994;213-219.
5. British Pharmacopoeia, 1988. UK, Vol. 1, p. 199.
6. Chafi N., Montheard J.P., Vergnaud J.M. Dosage form with drug attached to polymer (polyanhydride) dispersed in a Eudragit matrix: preparation and release of drug in gastric liquid. Int. J. Pharm. 45(3):1988;229-236.
7. Clarke, E.G.C., 1978. Isolation and Identification of Drugs, Vol. 1, p. 315.
8. Feely L.C., Davis S.S. The influence of polymeric excipients on drug release from hydroxypropylmethylcellulose matrices. Int. J. Pharm. 44(1-3):1988;131-139.
9. Ford J.L., Rubinstein M.H., McCaul F., Hogan J.E., Edgar P.J. Importance of drug type, tablet shape and added diluents on drug release kinetics from hydroxypropylmethyl-cellulose matrix tablets. Int. J. Pharm. 40(3):1987;223-234.
10. Handbook of Pharmaceutical Exipients, 1986. American Pharmaceutical Ass. and The Pharmaceutical Society of G.B. Production, The Pharmaceutical Press, USA.
11. Ishino R., Sunada H. Influence of drug solubility and matrix structure on release rate of drugs from wax matrix tablets. Chem. Pharm. Bull. 41(1):1993;196-200.
12. Ishino R., Sunada H. Studies on application of wax matrix system for controlled release. Chem. Pharm. Bull. 41(3):1993;586-589.
13. Kar A., Aniuha G.I. Spectrophotometric determination of dimenhydrinate with Reinecke salt. J. Pharm. Sci. 70(6):1981;690-691.
14. Kato Y., Sunada H., Yonezawa Y., Ishino R. Sustained release mechanisms of wax matrix system for controlled release. Chem. Pharm. Bull. 42(8):1994;1646-1650.
15. Leuenberger H., Bonny J.D., Kolb M. Percolation effects in matrix-type controlled drug release systems. Int. J. Pharm. 115:1995;217-224.
16. Malamataris S., Ganderton D. Sustained release from matrix system comprising hydrophobic and hydrophylic (gel-forming) parts. Int. J. Pharm. 70(1-2):1991;69-75.
17. Meshali M.M., El-Sayed G.M., Abdel-Aleem H.M., El-Said Y. Optimization of theophylline release from tablets containing compritol. S.T.P. Pharm. Sci. 5(6):1995;429-434.
18. Otsuka M., Onoe M., Matsuda Y. Hygroscopic stability and dissolution properties of spray-dried solid dispersions of furosemide with eudragit. J. Pharm. Sci. 82(1):1993;32-38.
19. Perez-Marcos B., Gutierrez C., Gomez-Amoza J.-L., Martinez-Pacheco R., Souto C., Concheiro A. Usefulness of certain varieties of carbomer in the Formulation of hydrophilic furosemide matrices. J. Pharm. Sci. 67:1991;113-121.
20. Rawlins, E.A., 1977. Bentley's Textbook of Pharmaceutics, 8th edn., 1977, p. 663.
21. Robinson J.R., Erikson S.P. Theoretical formulation of sustained-release dosage forms. J. Pharm. Sci. 55(11):1986;1254-1263.
22. Scavone J.M., Luna B.G., Harmatz J.S., Moltke L.V., Greenblatt D.J. Diphenhydramine kinetics following intravenous, oral and sublingual dimenhydrinate administration. Biopharm. Drug Dispos. 11:1990;185-189.
23. Sirkia T., Makimartti M., Liukko-Sipi S., Marvola M. Development and biopharmaceutical evaluations of a new press-coated prolonged-release salbutamol sulphate tablet in man. Eur. J. Pharm. Sci. 1(4):1994;195-201.
24. Skofitsch G., Lembeek F. Serum levels of dimenhydrinate. Arzneim-Forsch./Drug Res. 33(11):1983;1674-1676.
25. The Extra Pharmacopoeia, 1993, 13th edn. The Pharmaceutical Press, London, p. 936.
26. The United States Pharmacopoeia (USP XXII), 1990. Twinbrok, Parkway, Rock-ville, United States Pharmaceutical Convention, pp. 449-451 1788-1789, 1990.
27. Vazquez M.-J., Casalderry M., Duro R., Gomez-Amoza J.-L., Martinez-Pacheco R., Souto C., Concheiro A. Atenolol release from hydrophilic matrix tablets with hydroxypropylmethylcellulose mixtures as gelling agent: effects of the viscosity of the HPMC mixture. Eur. J. Pharm. Sci. 4(1):1996;39-48.
28. Wan L.S.C., Heng P.W.S., Wong L.F. The effect of hydroxypropylmethylcellulose on water penetration in to a matrix system. Int. J. Pharm. 73(2):1991;111-116.
29. Xu G., Sunada H. Influence of formulation change on drug release kinetics from hydroxypropylmethylcellulose matrix tablets. Chem. Pharm. Bull. 43(3):1995;483-487.